Regenxbio
RGNX
RGNX
182 hedge funds and large institutions have $778M invested in Regenxbio in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 183 → 182 (-1)
16% less capital invested
Capital invested by funds: $927M → $778M (-$149M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
182
Holding in Top 10
2
Calls
$1.84M
Puts
$1.53M
Top Buyers
| 1 | +$12.8M | |
| 2 | +$11.8M | |
| 3 | +$4.25M | |
| 4 |
BlackRock
New York
|
+$3.06M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.24M |
Top Sellers
| 1 | -$6.09M | |
| 2 | -$5.9M | |
| 3 | -$5.66M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.91M |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$1.99M |